Skip to main content

Oral Contraceptive Pills : Uses , Fuctions, Toxic Syndrommes..........



















Oral cotraceptive pills are tablets that prevents conception. Perhaps its the most accepted contraceptive method in developing countries. Its principle function is to prevent conception and it doesn't give any protection against HIV and other STD's.


Oral Contraceptive Pills (OCP) are mainly two types.

1. Combiled OCP.
2. Progesteron OR Estrogen only Pills.

The mechanism of action of OCP is very simple. We know that female Menstrual cycle is devided into three phases.

1. Proliferative phase : Here estrogen is secreted by Ovary , which causes uterine endrometrial growth. After this phase there is sudden withdrwal af estrogen which causes Ovulation ( It is the fall of mature ovum into Peritoneal Cavity , which ultimately comes into the uterine tube and finally in uterus ).

2. Secretory phase : Here both Progesterone and Estrogen Causes more and more growth if endometrium and increase secretion by the uterine glands.

3. The Menstrual phase : Here sudden Withdrawal of Progesterone cause increase uterine contraction and shedding out of uterine endometrium with mature Ovum , which is visible as bleeding.






















Now, OCP maintains a steady concentration of estrogen and progesterone into the body. Though , Ovulation occur due to sudden withdrawal of estrogen and OCP maintains estrogen level , so , there is no ovulation in the body. And , there is menstruation due to sudden withdrawal of progesterone , because , OCP intake should be stopped after 21 days. After this , the women will take 7 Iron tablets , and by this period there is sudden withdrwal of progesterone in the body. So , there is menstruation but without any ovulation.
Now, though there is no ovulation so , so Sperms inters into the vagina and uterus they can not find any mature ovum in female genital tract. So , there is no fertilization in the body. So, that women will not conceve .
By this way OCP maintains Contraception into the body.












Comments

Post a Comment

Popular posts from this blog

Artificial pancreas ... an option

Coming Soon: 'Artificial Pancreas' Options for Diabetes Miriam E Tucker June 20, 2016   NEW ORLEANS — Nearly closed-loop systems (also referred to as an "artificial pancreas") for improving glycemic control and minimizing hypoglycemia in type 1 diabetes are advancing rapidly, including iterations that deliver insulin alone, insulin with glucagon, or glucagon alone. Findings for several of the products in development demonstrating improvements in glycemic control and reductions in hypoglycemia were presented here at the  American Diabetes Association (ADA) 2016 Scientific Sessions . "Some people may do well on insulin only, while others may need glucagon," Vincent Crabtree, PhD, director of the artificial pancreas program at JDRF, in New York, told  Medscape Medical News , adding, "JDRF would like people to have choice, and we'd like all to be covered [by payers]." The insulin-only hybrid closed-loop 670G system (Medtronic MiniMed) is the...
Post a Comment
Read more
Liver Stem Cells Discovered in Mice Share on email Share on facebook Share on twitter Scientists successfully identified and grew a renewable population of liver stem cells for the first time, a new study reported. Tissues derived from these stem cells slightly boosted liver function when implanted into mice with a liver disorder. The findings could eventually lead to approaches that help rejuvenate damaged livers in people. A single cell was coaxed to mature into liver cells that produce common liver proteins (green and red).  Image courtesy of Huch et al.,  Nature . The liver is a large, versatile organ that has many jobs, including cleansing blood and digesting food. The liver also has a unique ability to quickly regenerate and regain its original size if partially removed by surgery. Scientists have long known that stem cells that have the potential to create more liver cells must exist in the adult liver. But until now, no one had found a way to detect a...
Post a Comment
Read more

Erythropoietin as a Retinal Angiogenic Factor in Proliferative Diabetic Retinopathy

Although vascular endothelial growth factor (VEGF) is a primary mediator of retinal angiogenesis, VEGF inhibition alone is insufficient to prevent retinal neovascularization. Hence, it is postulated that there are other potent ischemia-induced angiogenic factors. Erythropoietin possesses angiogenic activity, but its potential role in ocular angiogenesis is not established. METHODS We measured both erythropoietin and VEGF levels in the vitreous fluid of 144 patients with the use of radioimmunoassay and enzyme-linked immunosorbent assay. Vitreous proliferative potential was measured according to the growth of retinal endothelial cells in vitro and with soluble erythropoietin receptor. In addition, a murine model of ischemia-induced retinal neovascularization was used to evaluate erythropoietin expression and regulation in vivo. RESULTS The median vitreous erythropoietin level in 73 patients with proliferative diabetic retinopathy was significantly higher than that in 71 patients with...
Post a Comment
Read more